子宫腺肌症与子宫内膜癌相关:可能与病理、免疫组织化学和分子特征有关

IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Francesco La Torre , Yannick Hurni , Elisa Farsi , Eleonora Nardi , Francesca Castiglione , Flavia Sorbi , Maria Cristina Petrella , Massimiliano Fambrini , Felice Petraglia
{"title":"子宫腺肌症与子宫内膜癌相关:可能与病理、免疫组织化学和分子特征有关","authors":"Francesco La Torre ,&nbsp;Yannick Hurni ,&nbsp;Elisa Farsi ,&nbsp;Eleonora Nardi ,&nbsp;Francesca Castiglione ,&nbsp;Flavia Sorbi ,&nbsp;Maria Cristina Petrella ,&nbsp;Massimiliano Fambrini ,&nbsp;Felice Petraglia","doi":"10.1016/j.ygyno.2025.02.017","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/objective</h3><div>Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation between adenomyosis and the pathological, immunohistochemical (IHC), and molecular features of EC.</div></div><div><h3>Methods</h3><div>This retrospective cohort study analyzed 172 patients with EC who underwent surgical staging. Patients were stratified into two groups based on the presence of adenomyosis. The primary endpoint was the prevalence of FIGO stage ≥IB disease. Secondary endpoints included tumor histotype, grade, lymphovascular invasion, IHC markers, and molecular alterations. Logistic regression was performed to identify independent predictors of adverse pathological features.</div></div><div><h3>Results</h3><div>Adenomyosis was identified in 37.2 % of EC patients. These patients were younger, less likely to be postmenopausal, and exhibited significantly lower rates of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. Multivariate analysis confirmed adenomyosis as an independent protective factor against FIGO stage ≥IB disease. This protective effect could be attributed to the altered myometrial microenvironment in adenomyosis, characterized by inflammation, smooth muscle hyperplasia, and fibrosis, which appears to limit tumor invasiveness. No significant differences were observed in IHC or molecular profiles, although a trend toward higher prevalence of KRAS mutations was observed in patients with adenomyosis.</div></div><div><h3>Conclusion</h3><div>Adenomyosis was associated with a lower prevalence of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. These findings suggest that structural changes in the myometrial microenvironment may play a role in limiting tumor invasiveness and spread, warranting further investigation.</div></div>","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":"195 ","pages":"Pages 45-49"},"PeriodicalIF":4.5000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adenomyosis associated with endometrial cancer: Possible correlation with pathological, immunohistochemical and molecular characteristics\",\"authors\":\"Francesco La Torre ,&nbsp;Yannick Hurni ,&nbsp;Elisa Farsi ,&nbsp;Eleonora Nardi ,&nbsp;Francesca Castiglione ,&nbsp;Flavia Sorbi ,&nbsp;Maria Cristina Petrella ,&nbsp;Massimiliano Fambrini ,&nbsp;Felice Petraglia\",\"doi\":\"10.1016/j.ygyno.2025.02.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background/objective</h3><div>Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation between adenomyosis and the pathological, immunohistochemical (IHC), and molecular features of EC.</div></div><div><h3>Methods</h3><div>This retrospective cohort study analyzed 172 patients with EC who underwent surgical staging. Patients were stratified into two groups based on the presence of adenomyosis. The primary endpoint was the prevalence of FIGO stage ≥IB disease. Secondary endpoints included tumor histotype, grade, lymphovascular invasion, IHC markers, and molecular alterations. Logistic regression was performed to identify independent predictors of adverse pathological features.</div></div><div><h3>Results</h3><div>Adenomyosis was identified in 37.2 % of EC patients. These patients were younger, less likely to be postmenopausal, and exhibited significantly lower rates of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. Multivariate analysis confirmed adenomyosis as an independent protective factor against FIGO stage ≥IB disease. This protective effect could be attributed to the altered myometrial microenvironment in adenomyosis, characterized by inflammation, smooth muscle hyperplasia, and fibrosis, which appears to limit tumor invasiveness. No significant differences were observed in IHC or molecular profiles, although a trend toward higher prevalence of KRAS mutations was observed in patients with adenomyosis.</div></div><div><h3>Conclusion</h3><div>Adenomyosis was associated with a lower prevalence of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. These findings suggest that structural changes in the myometrial microenvironment may play a role in limiting tumor invasiveness and spread, warranting further investigation.</div></div>\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":\"195 \",\"pages\":\"Pages 45-49\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825825000538\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825825000538","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的子宫腺肌病是一种以炎症和高雌激素状态为特征的良性子宫疾病。它与子宫内膜癌(EC)的关系仍有争议。本研究旨在探讨子宫腺肌症与EC病理、免疫组化(IHC)及分子特征的相关性。方法回顾性队列研究分析了172例接受手术分期的EC患者。根据是否存在子宫腺肌症将患者分为两组。主要终点是FIGO≥IB期疾病的患病率。次要终点包括肿瘤组织型、分级、淋巴血管侵袭、免疫组化标志物和分子改变。采用逻辑回归来确定不良病理特征的独立预测因素。结果37.2%的EC患者有子宫腺肌症。这些患者较年轻,绝经后的可能性较小,FIGO≥IB期疾病、深部肌层浸润、淋巴血管浸润和子宫外扩散的发生率明显较低。多因素分析证实子宫腺肌症是FIGO≥IB期疾病的独立保护因子。这种保护作用可能归因于子宫腺肌症中肌层微环境的改变,其特征是炎症、平滑肌增生和纤维化,这似乎限制了肿瘤的侵袭性。尽管在子宫腺肌症患者中观察到KRAS突变有较高的流行趋势,但在免疫组化或分子谱方面没有观察到显著差异。结论子宫腺肌病与FIGO≥IB期疾病、深部肌层浸润、淋巴血管浸润和子宫外扩散的发生率较低有关。这些发现表明,子宫肌微环境的结构变化可能在限制肿瘤侵袭和扩散方面发挥作用,值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Adenomyosis associated with endometrial cancer: Possible correlation with pathological, immunohistochemical and molecular characteristics

Background/objective

Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation between adenomyosis and the pathological, immunohistochemical (IHC), and molecular features of EC.

Methods

This retrospective cohort study analyzed 172 patients with EC who underwent surgical staging. Patients were stratified into two groups based on the presence of adenomyosis. The primary endpoint was the prevalence of FIGO stage ≥IB disease. Secondary endpoints included tumor histotype, grade, lymphovascular invasion, IHC markers, and molecular alterations. Logistic regression was performed to identify independent predictors of adverse pathological features.

Results

Adenomyosis was identified in 37.2 % of EC patients. These patients were younger, less likely to be postmenopausal, and exhibited significantly lower rates of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. Multivariate analysis confirmed adenomyosis as an independent protective factor against FIGO stage ≥IB disease. This protective effect could be attributed to the altered myometrial microenvironment in adenomyosis, characterized by inflammation, smooth muscle hyperplasia, and fibrosis, which appears to limit tumor invasiveness. No significant differences were observed in IHC or molecular profiles, although a trend toward higher prevalence of KRAS mutations was observed in patients with adenomyosis.

Conclusion

Adenomyosis was associated with a lower prevalence of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. These findings suggest that structural changes in the myometrial microenvironment may play a role in limiting tumor invasiveness and spread, warranting further investigation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Gynecologic oncology
Gynecologic oncology 医学-妇产科学
CiteScore
8.60
自引率
6.40%
发文量
1062
审稿时长
37 days
期刊介绍: Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信